QXO, Inc.
QXO
$11.44
-5.53%
QXO, Inc. is a North American distributor of building products operating in the roughly $800 billion building products distribution industry, serving contractors and builders across roofing, insulation, and related categories. The company is positioning itself as a tech-enabled consolidator, explicitly targeting nearly $50 billion in annual revenue within a decade through accretive acquisitions and organic growth — a strategy that has transformed it from a small-cap shell into a large-cap platform with a market capitalization near $12–14 billion and roughly 7,800 employees. The dominant investor narrative is now the transformative $17 billion acquisition of TopBuild, announced in April 2026, which would dramatically scale the business and diversify its end markets but has raised significant concerns about dilution, integration risk, and near-term profitability. This debate is playing out in a stock that has fallen sharply over the past year, with investors weighing the long-term consolidation thesis against the execution and balance-sheet risks of digesting a deal of this magnitude.…
QXO
QXO, Inc.
$11.44
Related headlines
Investment Opinion: Should I buy QXO Today?
The synthesized recommendation for QXO is a Hold, reflecting a highly speculative situation where the long-term consolidation thesis is compelling but near-term execution risks and deteriorating fundamentals warrant caution. The analyst consensus is a strong buy with an average target price of $29.11, implying 136% upside, but this optimism contrasts sharply with the stock's 42.1% one-year decline and deeply negative profitability. The core thesis is that QXO is a high-risk, high-reward bet on a successful integration of TopBuild and a return to profitability, but until there is tangible progress, the risk/reward is not compelling enough for a Buy rating.
The supporting evidence for a Hold is mixed. On the positive side, revenue grew 127.1% year-over-year in Q1 2026, the balance sheet is strong with $3.05 billion in cash and a current ratio of 3.58, and the stock trades at a modest PS of 1.73x and PB of 1.22x. However, profitability is deeply negative with a net margin of -13.1%, gross margin has compressed to 14.2%, and free cash flow yield is just 1.7%. The forward PE of 19.1x requires a dramatic turnaround to justify, and the sequential revenue decline of 36.6% over two quarters raises red flags. While the analyst community is unanimously bullish, the lack of downgrades despite the stock's collapse suggests estimates may be stale.
The biggest risks that could invalidate the thesis include integration missteps with TopBuild, continued margin compression, and a breakdown below the 52-week low of $12.17. The rating would upgrade to Buy if the company demonstrates a clear path to profitability, such as positive EBITDA and improving gross margins above 16%, or if the stock stabilizes and breaks above key resistance levels. Conversely, a downgrade to Sell would be warranted if revenue growth decelerates further, margins fall below 12%, or the company requires additional dilutive financing. Relative to its history and peers, QXO appears undervalued on a price-to-sales basis, but the premium on forward earnings and the lack of current profitability make it a speculative value play rather than a clear bargain.
Sign up to view all
QXO 12-Month Price Forecast
QXO presents a high-risk, high-reward opportunity that is currently in a precarious position. The company's transformative acquisition of TopBuild could unlock significant value, but near-term fundamentals are deteriorating, with widening losses and margin compression. The stock's severe downtrend and high beta make it unsuitable for risk-averse investors, while the unanimous analyst bullishness suggests potential upside if execution improves. I would upgrade to bullish if QXO demonstrates a clear path to profitability, such as positive EBITDA and stabilizing gross margins above 16%. Conversely, I would downgrade to bearish if the stock breaks below $12.17 or if the company reports another quarter of significant losses and negative free cash flow.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on QXO, Inc.'s 12-month outlook, with a consensus price target around $29.11 and implied upside of +154.5% versus the current price.
Average Target
$29.11
0 analysts
Implied Upside
+154.5%
vs. current price
Analyst Count
—
covering this stock
Price Range
$18 - $50
Analyst target range
Coverage of QXO is robust, with 18 analysts contributing to a consensus recommendation of "strong buy" (recommendation mean of 1.22 on a 1–5 scale where 1 is a strong buy) and an average target price of $29.11. Against the current price of $12.31, that average target implies upside of approximately 136%, an extraordinarily wide gap that reflects either a significant mispricing opportunity or analyst estimates that have not yet caught up to the deteriorating price action and fundamental results. The consensus is unambiguously bullish — the institutional ratings data shows a steady stream of Outperform, Overweight, and Buy ratings from RBC Capital, KeyBanc, Citigroup, Stephens, Baird, and Oppenheimer throughout 2026, with no downgrades or negative actions — but the persistence of these ratings while the stock has fallen 42% over the past year suggests analysts are anchoring on the long-term consolidation thesis rather than near-term results. The consensus revenue estimate of $33.2 billion and EPS estimate of $2.12 imply a dramatic transformation from the current run-rate, and the bullish stance is effectively a bet that the TopBuild acquisition and subsequent M&A will deliver the promised scale and profitability. The target price range is extremely wide, from a low of $18.00 to a high of $50.00 — a 178% spread between the two — which signals very high uncertainty and low conviction about the company's trajectory. The high target of $50.00 implies a market capitalization of roughly $37 billion and assumes successful integration of TopBuild, multiple expansion, and a return to profitability that would justify a premium valuation; the low target of $18.00 still implies 46% upside from the current price but prices in significant margin compression, integration missteps, and the possibility that the acquisition proves dilutive for longer than expected. Notably, even the lowest analyst target sits 46% above the current price, meaning the entire analyst community believes the stock is undervalued — a rare unanimity that, combined with the stock's relentless decline, suggests either a compelling contrarian opportunity or a case where the sell-side is systematically underestimating the risks. The absence of any downgrades despite a 42% one-year decline is itself a signal worth scrutinizing: it may indicate strong conviction in the long-term story, or it may indicate that estimates are stale and vulnerable to downward revisions if the next few quarters fail to show progress toward profitability.
Bulls vs Bears: QXO Investment Factors
The bear case currently has stronger evidence, driven by QXO's severe and accelerating downtrend, deeply negative profitability, and deteriorating sequential revenue. The stock trades at just 0.9% above its 52-week low, with no technical signs of stabilization, and the company remains dependent on external financing to fund its strategy. However, the bull case rests on a unanimous strong buy analyst consensus and a transformative acquisition that could dramatically scale the business if executed successfully. The single most important tension is whether the TopBuild acquisition will prove accretive and drive a profitability inflection, or whether integration challenges and dilution will continue to erode shareholder value. Until there is concrete evidence of margin recovery and positive earnings, the risk/reward remains skewed to the downside despite the compelling long-term consolidation thesis.
Bullish
- Unanimous Strong Buy Consensus: All 18 covering analysts rate QXO a strong buy (recommendation mean 1.22), with an average target price of $29.11 implying 136% upside from $12.31. Even the lowest target of $18.00 sits 46% above the current price, indicating the entire sell-side views the stock as deeply undervalued.
- Transformative TopBuild Acquisition: The $17 billion TopBuild deal announced in April 2026 would dramatically scale QXO's revenue and diversify its end markets, positioning it toward its stated goal of nearly $50 billion in annual revenue within a decade. The acquisition is expected to be accretive and could accelerate the path to profitability.
- Fortress Balance Sheet: QXO holds $3.05 billion in cash with a current ratio of 3.58 and a modest debt-to-equity of 0.40, providing substantial liquidity to fund the TopBuild acquisition and integration. This financial flexibility reduces near-term solvency risk and supports the consolidation strategy.
- Deep Value on Price-to-Sales: At a PS ratio of 1.73x and PB of 1.22x, QXO trades near the low end of its historical valuation band, despite revenue growing 127.1% year-over-year in Q1 2026. The forward PE of 19.1x implies the market expects a swing to profitability, which could drive significant multiple expansion if achieved.
Bearish
- Severe and Accelerating Downtrend: QXO is down 42.1% over the past year and 37.6% year-to-date, with the decline accelerating recently (-18.1% over one month, -26.0% over three months). The stock sits just 0.9% above its 52-week low of $12.17, signaling persistent selling pressure and no evidence of a bottom.
- Deeply Negative Profitability: Q1 2026 net income was -$227.1 million on $1.73 billion of revenue, a net margin of -13.1%, with gross margin compressing to 14.2% from 17.5% in Q3 2025. EBITDA swung from +$87.2 million in Q4 2025 to -$59.6 million in Q1 2026, showing the company is moving further from profitability.
- Deteriorating Sequential Revenue: Revenue fell from $2.73 billion in Q3 2025 to $2.19 billion in Q4 2025 to $1.73 billion in Q1 2026, a 36.6% decline over two quarters. This raises questions about the underlying health of the legacy business and suggests the growth story is entirely dependent on M&A rather than organic momentum.
- Integration and Dilution Risk: The $17 billion TopBuild acquisition has raised concerns about dilution and integration risk, with the company raising $750.4 million of common stock in Q1 2026 alone. The deal's success is unproven, and any missteps could further pressure the stock.
QXO Technical Analysis
QXO is in a sustained and severe downtrend, with the shares down 42.1% over the past year and 37.6% year-to-date, a stark underperformance versus the S&P 500's +16.2% one-year return. At $12.31, the stock is trading at just 0.9% above its 52-week low of $12.17 and only 44.6% of its 52-week high of $27.61, meaning it sits essentially at the bottom of its annual range — a positioning that signals persistent selling pressure and a lack of buyer conviction rather than a value opportunity, given the absence of any stabilization. The maximum drawdown of -54.6% over the period confirms a deep, structural decline rather than a routine pullback. Short-term momentum reinforces the bearish picture: the stock is down 18.1% over the past month and 26.0% over three months, with both figures worse than the one-year decline on a relative basis, indicating that the selling has actually accelerated recently rather than abated. Relative strength versus SPY is negative across every window — -17.0% over one month, -29.0% over three months, and -58.3% over one year — a consistent pattern of underperformance that argues against calling a bottom. The 1-month decline of 18.1% versus the 1-year decline of 42.1% shows the stock is still in the steepest phase of its decline, with no evidence of mean reversion or a momentum trough; the short ratio of 6.49 days suggests meaningful short interest that could fuel sharp squeezes on any positive catalyst, but the trend remains decisively down. Key technical levels are clear: the 52-week low at $12.17 is the immediate support, and a breakdown below it would signal a continuation of the downtrend into price discovery with no historical floor, while the 52-week high at $27.61 represents distant resistance that would require a 124% rally to reclaim. With a beta of 2.291, QXO is roughly 129% more volatile than the market, meaning its daily swings are more than double SPY's — this amplifies both downside risk in the current downtrend and potential upside on any reversal, and demands materially smaller position sizes for equivalent risk exposure. The combination of a stock at its lows, a beta above 2, and accelerating negative momentum makes this a high-risk setup where catching the falling knife is dangerous until price action confirms a base.
Beta
2.29
2.29x market volatility
Max Drawdown
-57.7%
Largest decline past year
52-Week Range
$11-$28
Price range past year
Annual Return
-46.1%
Cumulative gain past year
| Period | QXO Return | S&P 500 |
|---|---|---|
| 1m | -21.2% | -2.4% |
| 3m | -30.9% | +2.2% |
| 6m | -43.6% | +14.8% |
| 1y | -46.1% | +14.6% |
| ytd | -42.0% | +11.1% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
QXO Fundamental Analysis
QXO's revenue trajectory has been transformed by acquisition, with Q1 2026 revenue of $1.73 billion representing 127.1% year-over-year growth, but the sequential trend is deteriorating: revenue fell from $2.73 billion in Q3 2025 to $2.19 billion in Q4 2025 to $1.73 billion in Q1 2026, a 36.6% decline over two quarters that reflects either seasonality, divestitures, or demand weakness in the core distribution business. The company reports a single reportable segment of $1.73 billion, so there is no segment-level disclosure to identify which business lines are driving or dragging growth, though the pending TopBuild acquisition would add significant scale and diversification. The growth story is therefore entirely dependent on M&A rather than organic momentum, and the sequential revenue decline raises questions about the underlying health of the legacy business even as the headline YoY figure looks impressive. Profitability remains deeply negative: Q1 2026 net income was -$227.1 million on $1.73 billion of revenue, a net margin of -13.1%, with gross margin of 14.2% — a level that is thin for industrial distribution and leaves little room for error. The loss widened dramatically from -$90.2 million in Q4 2025 and -$139.4 million in Q3 2025, and EBITDA swung from +$87.2 million in Q4 2025 to -$59.6 million in Q1 2026, a deterioration that reflects both integration costs and the burden of a cost structure that is not yet scaled to revenue. Gross margin has also compressed, from 17.5% in Q3 2025 to 16.9% in Q4 2025 to 14.2% in Q1 2026, suggesting pricing pressure or unfavorable mix, and the operating margin of -11.8% in Q1 2026 versus -1.8% in Q4 2025 shows the company is moving further from, not closer to, profitability. The balance sheet is the one area of relative strength: the current ratio is 3.58, debt-to-equity is a modest 0.40, and cash at the end of Q1 2026 stood at $3.05 billion, providing substantial liquidity to fund the TopBuild acquisition and integration. However, free cash flow is thin relative to the capital deployed — TTM FCF of $195.6 million against a market cap of roughly $11.8 billion implies an FCF yield of just 1.7% — and ROE of -2.9% and ROA of -0.3% confirm that the company is not yet generating adequate returns on its asset base. The Q1 2026 cash flow statement shows operating cash flow of only $70.6 million against $227.1 million of net loss, with the gap bridged by $164.2 million of depreciation and amortization and $100 million of working capital release, and the company raised $750.4 million of common stock in the quarter — a clear signal that it remains dependent on external financing rather than internal cash generation to fund its strategy.
Quarterly Revenue
$1.7B
2026-03
Revenue YoY Growth
N/A
YoY Comparison
Gross Margin
14.2%
Latest Quarter
Free Cash Flow
$195600999.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is QXO Overvalued?
Because QXO's trailing net income is negative (-$227.1 million in Q1 2026, with a trailing PE of -30.6x), the PE ratio is not meaningful, and the appropriate primary metric is the price-to-sales ratio, which stands at 1.73x on a trailing basis. The forward PE of 19.1x is the more informative figure, as it implies the market expects the company to swing to meaningful profitability — consensus estimated EPS of $2.12 against a current price of $12.31 — and the enormous gap between the negative trailing PE and the positive forward PE captures the entire bull-bear debate: the market is pricing in a successful integration and margin recovery that has not yet materialized. The EV/Sales of 2.02x and EV/EBITDA of 51.6x further illustrate that the company is being valued on future earnings power rather than current cash flows, with the EV/EBITDA multiple especially stretched given the negative EBITDA in the most recent quarter. On a peer-comparison basis, the data provided does not include an explicit industry average for the Industrial - Distribution sector, so a direct multiple-to-peer spread cannot be quantified; however, a PS of 1.73x and EV/Sales of 2.02x are not obviously expensive in absolute terms for a distribution business, and the PB ratio of 1.22x is modest, suggesting the market is not ascribing a large premium to the platform. The premium that does exist is embedded in the forward PE of 19.1x, which requires the company to deliver on its $2.12 consensus EPS estimate — a forecast that assumes a dramatic turnaround from the current -$0.35 quarterly EPS and would represent a valuation that is only justified if the TopBuild acquisition is accretive and integration proceeds smoothly. Historically, QXO's valuation metrics have been extremely volatile and distorted by its pre-acquisition shell-company status: the PS ratio was above 400x in 2024 and above 600x in 2023 when revenue was negligible, and the PB ratio exceeded 800x in 2023 before collapsing to 1.22x today as the balance sheet was recapitalized. The current PS of 1.73x is therefore near the low end of the company's own historical band, but this comparison is of limited value because the business has fundamentally changed — the relevant question is not where QXO traded as a shell, but whether 1.73x sales and 19.1x forward earnings are appropriate for a leveraged, integration-heavy distributor with negative current margins. The stock's decline from a 52-week high of $27.61 to $12.31 has compressed the valuation meaningfully, but the market is clearly skeptical that the forward estimates are achievable, and until profitability inflects, the valuation will remain a bet on execution rather than a reflection of current fundamentals.
PE
-30.6x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 13x~122x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
51.6x
Enterprise Value Multiple
Investment Risk Disclosure
QXO faces significant financial and operational risks, primarily stemming from its deeply negative profitability and cash burn. In Q1 2026, the company reported a net loss of -$227.1 million on $1.73 billion of revenue, with a net margin of -13.1% and an operating margin of -11.8%. Gross margin has compressed from 17.5% in Q3 2025 to 14.2% in Q1 2026, leaving little room for error in a thin-margin distribution business. Free cash flow is thin relative to capital deployed, with TTM FCF of $195.6 million against a market cap of roughly $11.8 billion, implying an FCF yield of just 1.7%. The company raised $750.4 million of common stock in Q1 2026, highlighting its dependence on external financing to fund the TopBuild acquisition and ongoing operations. Additionally, the sequential revenue decline of 36.6% over two quarters raises concerns about the underlying health of the legacy business and the sustainability of its growth trajectory.
Market and competitive risks are amplified by QXO's extreme volatility and premium valuation relative to its current fundamentals. With a beta of 2.291, the stock is roughly 129% more volatile than the market, meaning it is highly sensitive to macro shifts and sector rotation. The forward PE of 19.1x and EV/EBITDA of 51.6x price in a dramatic turnaround that has not yet materialized, leaving the stock vulnerable to multiple compression if profitability fails to inflect. The recent news highlights the $17 billion TopBuild acquisition as a transformative but risky bet, with competitors like IBP potentially offering a safer alternative. The absence of any analyst downgrades despite a 42% one-year decline suggests estimates may be stale and vulnerable to downward revisions if upcoming quarters fail to show progress. Furthermore, the stock's relative strength versus SPY is negative across all time frames, indicating persistent underperformance that could continue if the integration disappoints.
The worst-case scenario for QXO involves a failed integration of TopBuild, continued margin compression, and a breakdown below the 52-week low of $12.17. In this scenario, the stock could retest its historical lows or fall further into price discovery, with the analyst low target of $18.00 offering little support given the current price of $12.31. A drop to the 52-week low represents a decline of approximately 1.1% from current levels, but a more severe sell-off could see the stock fall 20-30% to the $8-10 range if the company reports another quarter of widening losses and negative free cash flow. The maximum drawdown of -54.6% over the past year illustrates the potential magnitude of losses in an adverse scenario. Investors could lose 35% or more from the current price if the bear case fully materializes, especially given the stock's high beta and lack of technical support.
FAQ
The key risks for QXO are ranked as follows: First, integration and execution risk from the $17 billion TopBuild acquisition, which could lead to cost overruns, delays, and further dilution. Second, financial risk from deeply negative profitability, with a net margin of -13.1% and free cash flow yield of just 1.7%, requiring external financing. Third, market risk due to the stock's high beta of 2.291, making it highly volatile and sensitive to macro shifts. Fourth, competitive risk from rivals like IBP that may offer safer alternatives in the building products distribution space. Additionally, the stock is in a severe downtrend, down 42.1% over one year, and could break below its 52-week low of $12.17, leading to further losses.
The 12-month forecast for QXO includes three scenarios: a bull case with 25% probability targeting $29-50, a base case with 50% probability targeting $18-29, and a bear case with 25% probability targeting $8-12.17. The base case is most likely, assuming gradual integration progress but continued margin pressure, with the stock trading between the analyst low and average targets. The bull case requires successful integration and a return to profitability, while the bear case involves failed integration and a breakdown below the 52-week low. The key assumption behind the base case is that QXO stabilizes its gross margin around 15-16% and avoids further dilutive financing. Analyst estimates for revenue and EPS are $33.2 billion and $2.12, respectively, but these may be revised if near-term results disappoint.
QXO appears undervalued on a price-to-sales basis, trading at 1.73x trailing sales and 1.22x book value, which is near the low end of its historical range. However, the forward PE of 19.1x and EV/EBITDA of 51.6x suggest the market is pricing in a significant earnings recovery that has not yet materialized. The trailing PE is negative at -30.6x due to a net loss of -$227.1 million in Q1 2026. Compared to peers, the PS ratio is not obviously expensive for a distribution business, but the premium on forward earnings reflects high expectations. The valuation implies the market expects QXO to successfully integrate TopBuild and achieve consensus EPS of $2.12, which would represent a dramatic turnaround. If those expectations are met, the stock could be undervalued; if not, it is overvalued relative to current fundamentals.
QXO is a high-risk, speculative buy that is only suitable for aggressive investors with a long time horizon. The stock trades at $12.31, just 0.9% above its 52-week low, and has fallen 42.1% over the past year, reflecting deep pessimism. However, the analyst consensus is a strong buy with an average target of $29.11, implying 136% upside, based on the transformative potential of the $17 billion TopBuild acquisition. The biggest downside risk is that integration fails and the stock breaks below $12.17, potentially falling to $8-10. For risk-tolerant investors who believe in the consolidation thesis, the risk/reward may be attractive, but others should wait for evidence of a profitability inflection before buying.
QXO is more suitable for long-term investment than short-term trading, given its high volatility and the multi-year nature of its consolidation strategy. The stock's beta of 2.291 makes it extremely volatile, with daily swings more than double the market's, which is risky for short-term traders. The company pays a minimal dividend with a yield of 0.89%, so income is not a consideration. Earnings visibility is low, with negative net income and a forward PE of 19.1x that depends on a successful turnaround. A suggested minimum holding period is 3-5 years to allow for the integration of TopBuild and the realization of synergies. Short-term traders might capitalize on volatility, but the risk of catching a falling knife is high, as the stock is down 42.1% over the past year and shows no signs of stabilization.